|
CBL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.525400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.493800E-01 |
| Normal-vs-Stage2 |
4.671400E-01 |
| Normal-vs-Stage3 |
9.354200E-01 |
| Normal-vs-Stage4 |
1.904240E-01 |
| Stage1-vs-Stage2 |
3.221800E-01 |
| Stage1-vs-Stage3 |
6.484400E-01 |
| Stage1-vs-Stage4 |
4.977400E-01 |
| Stage2-vs-Stage3 |
6.519000E-01 |
| Stage2-vs-Stage4 |
1.652600E-01 |
| Stage3-vs-Stage4 |
4.195200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.854200E-01 |
| Normal-vs-AfricanAmerican |
9.659000E-01 |
| Normal-vs-Asian |
6.449600E-01 |
| Caucasian-vs-AfricanAmerican |
7.922400E-01 |
| Caucasian-vs-Asian |
6.863200E-01 |
| AfricanAmerican-vs-Asian |
6.252400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.717800E-01 |
| Normal-vs-Female |
3.299600E-02 |
| Male-vs-Female |
2.015900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.637400E-01 |
| Normal-vs-Extreme_Weight |
6.394300E-02 |
| Normal-vs-Obese |
2.282600E-01 |
| Normal-vs-Extreme_Obese |
2.870000E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.680000E-01 |
| Normal_Weight-vs-Obese |
8.223900E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.476000E-01 |
| Extreme_Weight-vs-Obese |
8.364200E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.979000E-01 |
| Obese-vs-Extreme_Obese |
2.404600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.321620E-01 |
| Normal-vs-Age(41-60Yrs) |
2.199600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.273210E-01 |
| Normal-vs-Age(81-100Yrs) |
4.814400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.145200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.624200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.243500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.698900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.194400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.257800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.631400E-01 |
| Normal-VS-Type2 PRCC |
1.657440E-01 |
| Normal-VS-KIRP CIMP |
5.532000E-02 |
| Normal-VS-Unclassified PRCC |
1.045810E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.299800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.497960E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.025900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.537600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.924070E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.293200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.410200E-01 |
| Normal-vs-N1 |
5.179000E-01 |
| Normal-vs-N2 |
4.686800E-01 |
| N0-vs-N1 |
1.052780E-01 |
| N0-vs-N2 |
9.773000E-01 |
| N1-vs-N2 |
5.395800E-01 |
|
|
